These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 18437320)

  • 1. Studies of enzymes that cause resistance to aminoglycosides antibiotics.
    Serpersu EH; Ozen C; Wright E
    Methods Mol Med; 2008; 142():261-71. PubMed ID: 18437320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aminoglycoside-modifying enzymes: mechanisms of catalytic processes and inhibition.
    Azucena E; Mobashery S
    Drug Resist Updat; 2001 Apr; 4(2):106-17. PubMed ID: 11512519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescence polarization immunoassay to determine aminoglycoside modifying enzymes activity.
    Pagani L; Perduca M; Mills V; Romero E
    Microbiologica; 1986 Oct; 9(4):423-30. PubMed ID: 3022111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial resistance to aminoglycoside antibiotics.
    Davies J; Wright GD
    Trends Microbiol; 1997 Jun; 5(6):234-40. PubMed ID: 9211644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular understanding of aminoglycoside action and resistance.
    Jana S; Deb JK
    Appl Microbiol Biotechnol; 2006 Mar; 70(2):140-50. PubMed ID: 16391922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A growing clinical problem: plasmid-determined resistance to aminocyclitol-aminoglycosides in enterobacteria.
    Gómez-Lus R; Rivera MJ; Vitoria MA
    Chemioterapia; 1984 Dec; 3(6):368-70. PubMed ID: 6099225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic modification of aminoglycoside antibiotics in gentamicin-resistant gram-negative bacteria.
    Kettner M; Navarová J; Lebek G; Krcméry V
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Aug; 257(3):372-82. PubMed ID: 6091367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective modification of the 3''-amino group of kanamycin prevents significant loss of activity in resistant bacterial strains.
    Santana AG; Zárate SG; Asensio JL; Revuelta J; Bastida A
    Org Biomol Chem; 2016 Jan; 14(2):516-525. PubMed ID: 26501183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aminoglycoside resistance in gramnegative pathogens of nosocomial infections in Russia].
    Reshed'ko GK
    Antibiot Khimioter; 2004; 49(5):11-23. PubMed ID: 15573898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Occurrence of aminoglycoside-modifying enzymes in resistant strains of enterobacteria and Pseudomonas aeruginosa from several countries.
    Kettner M; Navarová J; Rýdl Z; Knothe H; Lebek G; Krcméry V
    J Antimicrob Chemother; 1981 Sep; 8(3):175-85. PubMed ID: 6270050
    [No Abstract]   [Full Text] [Related]  

  • 11. [Future development of antibiotics. 3. Aminoglycoside antibiotics].
    Mitsuhashi S; Iyobe S; Okamoto R; Yamaji S
    Nihon Rinsho; 1984 Mar; 42(3):540-6. PubMed ID: 6088839
    [No Abstract]   [Full Text] [Related]  

  • 12. Transferable resistance and aminoglycoside-modifying enzymes in enterococci.
    Chen HY; Williams JD
    J Med Microbiol; 1985 Oct; 20(2):187-96. PubMed ID: 2995676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoglycoside-modifying enzymes.
    Wright GD
    Curr Opin Microbiol; 1999 Oct; 2(5):499-503. PubMed ID: 10508725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the use of conformationally locked aminoglycosides as a new strategy to overcome bacterial resistance.
    Bastida A; Hidalgo A; Chiara JL; Torrado M; Corzana F; Pérez-Cañadillas JM; Groves P; Garcia-Junceda E; Gonzalez C; Jimenez-Barbero J; Asensio JL
    J Am Chem Soc; 2006 Jan; 128(1):100-16. PubMed ID: 16390137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres).
    Dubois V; Arpin C; Dupart V; Scavelli A; Coulange L; André C; Fischer I; Grobost F; Brochet JP; Lagrange I; Dutilh B; Jullin J; Noury P; Larribet G; Quentin C
    J Antimicrob Chemother; 2008 Aug; 62(2):316-23. PubMed ID: 18467306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Resistance of gram-negative bacilli to 6 aminoglycosides].
    Broussain MT; Pinto ME; Cona E
    Rev Med Chil; 1985 Dec; 113(12):1210-6. PubMed ID: 3016857
    [No Abstract]   [Full Text] [Related]  

  • 17. Aminoglycoside antibiotics. Chemistry, biochemistry, structure-activity relationships.
    Reden J; Dürckheimer W
    Top Curr Chem; 1979; 83():105-170. PubMed ID: 384601
    [No Abstract]   [Full Text] [Related]  

  • 18. Aminoglycoside antibiotic resistance by enzymatic deactivation.
    Smith CA; Baker EN
    Curr Drug Targets Infect Disord; 2002 Jun; 2(2):143-60. PubMed ID: 12462145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of vertilmicin to modifications by three types of recombinant aminoglycoside-modifying enzymes.
    Yuan M; Han H; Li CR; Yang XY; Li GQ; Cen S; Kang XX; Si SY; Jiang JD; You XF
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3950-3. PubMed ID: 21646489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Aminosides: mode of action, pharmacology and mechanisms of resistance].
    Courvalin P; Leroy A
    Rev Prat; 1988 May; 38(16):987-92. PubMed ID: 2841749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.